Abstract
The development of 3D printing techniques allows the advance of personalized medicine, which is based on designing treatments, individuality of patients and their specific comorbidity, in order to improve adherence and safety in therapeutic management. The importance of this technique is the fact that it allows designing the characteristics of the treatment in order to offer a solution to the problem associated with polypharmacy in geriatric patients, by reducing the amount of drugs they must use daily and also by combining several active compounds in one. With this technique we can increase adherence, safety and tolerability to the treatment of each patient. The objective of this manuscript is to investigate the importance of the development of 3D printing drugs and how this technique increases adherence to therapies in geriatic population, as well as to reduce the risks associated with polypharmacy in this demographic group. 3D printing drugs improves the quality of life in polymedicated geriatric population, however, currently there is not enough studies which is why it is important to continue with the development of research to identify the advantage and limitations of this technology.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Kassandra Zúiga Gámez, Paula Castañeda Pinto, Libny Castellanos Betancourth, María José Cristofori da Silva, Katherine Durán Chavarría